Bhubaneswar: CARE Hospitals, Bhubaneswar a name synonyms with evidence-based treatment practices has initiated a sigh of relief for the people of Odisha with administration of Fasenra, Astrazeneca’s first respiratory biologic, now approved as an add-on maintenance treatment for severe asthma.

The first patient was administered with this injection yesterday by Dr. Damodar Bindhani (Clinical Director & HOD – Pulmonology). A sizeable number of asthma patients have severe asthma which may be uncontrolled despite high dosages of asthma controller medicines.

Severe, uncontrolled asthma is debilitating and potentially fatal, with patients experiencing frequent exacerbations and significant limitations on lung function and health-related quality of life. Patients with frequent hospitalization, low lung function, exacerbation and use of prolonged oral corticosteroid can now avail this medication at CARE Hospitals Bhubaneswar.